Oct 1, 2012
By:
Stephanie Sutton
The European Medicines Agency has updated its guidance on biosimilar medicines, with the aim of helping companies to avoid unnecessary repetition of clinical trials.
|
Sep 27, 2012
By:
Stephanie Sutton
Sanofi is planning to shed approximately 900 jobs in France in the lead up to 2015 as it seeks to implement certain key strategic objectives.
|
Sep 25, 2012
By:
Stephanie Sutton
The European Medicines Agency has abolished its Cell-based Product Working Party and Gene Therapy Working Party, with the aim of improving efficiencies and optimizing the use of available expertise.
|
Sep 20, 2012
By:
Stephanie Sutton
This year's CPhI Worldwide event is set to take place at the Feria de Madrid in Spain, October 9-12, with expectations for more than 30000 visitors and 2200 exhibitors from 140 countries.
|
Sep 19, 2012
By:
Stephanie Sutton
Johnson & Johnson has announced plans to open four innovation centers in California, Boston, London, and China, with the aim of accelerating early innovation and facilitating collaboration and investment opportunities.
|
Sep 18, 2012
By:
Stephanie Sutton
The European Generic Medicines Association (EGA) has raised concerns about the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities
|
Sep 10, 2012
By:
Stephanie Sutton
Eli Lilly has received an FDA Warning Letter because of a "misleading" image of a multicolored brain that appeared on the company's website for the diagnostic PET tracer, Amyvid.
|
Sep 5, 2012
By:
Stephanie Sutton
Merck KGaA has announced plans to eliminate 1100 jobs in Germany by the end of 2015—almost 10% of the company's 10,900 German positions.
|
|
October will see the implementation of FDA's Generic Drug User Fee Amendments of 2012.
Sep 4, 2012
By:
Stephanie Sutton
Generic-drug manufacturers are preparing to pay fees to FDA for the first time in the agency’s history.
|
|
